|
TRIM35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.53870000000934E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.040500E-04 |
| Normal-vs-Stage2 |
5.973600E-02 |
| Normal-vs-Stage3 |
1.889810E-02 |
| Normal-vs-Stage4 |
2.094400E-01 |
| Stage1-vs-Stage2 |
8.778600E-01 |
| Stage1-vs-Stage3 |
8.904200E-01 |
| Stage1-vs-Stage4 |
1.630230E-02 |
| Stage2-vs-Stage3 |
9.782200E-01 |
| Stage2-vs-Stage4 |
4.772200E-02 |
| Stage3-vs-Stage4 |
2.673700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.239500E-04 |
| Normal-vs-AfricanAmerican |
1.203850E-03 |
| Normal-vs-Asian |
7.312000E-02 |
| Caucasian-vs-AfricanAmerican |
4.742200E-01 |
| Caucasian-vs-Asian |
3.863900E-02 |
| AfricanAmerican-vs-Asian |
2.591900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.52109999999439E-05 |
| Normal-vs-Female |
1.235970E-02 |
| Male-vs-Female |
4.957800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.573200E-01 |
| Normal-vs-Extreme_Weight |
4.637200E-03 |
| Normal-vs-Obese |
2.647900E-04 |
| Normal-vs-Extreme_Obese |
8.172000E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.283400E-01 |
| Normal_Weight-vs-Obese |
1.508230E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.431450E-01 |
| Extreme_Weight-vs-Obese |
1.705820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.171200E-01 |
| Obese-vs-Extreme_Obese |
4.985800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.532400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.72000000000705E-05 |
| Normal-vs-Age(61-80Yrs) |
4.543300E-03 |
| Normal-vs-Age(81-100Yrs) |
9.728000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.262400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.384600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.228200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.616590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.096800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.756000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.13419999999643E-05 |
| Normal-VS-Type2 PRCC |
1.858800E-03 |
| Normal-VS-KIRP CIMP |
7.574400E-01 |
| Normal-VS-Unclassified PRCC |
1.581540E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.733000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.740180E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.777600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.478600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.707400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.498000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.156400E-02 |
| Normal-vs-N1 |
7.606000E-01 |
| Normal-vs-N2 |
7.404400E-01 |
| N0-vs-N1 |
2.573600E-01 |
| N0-vs-N2 |
6.489200E-01 |
| N1-vs-N2 |
9.350200E-01 |
|
|
